0.02  0.005 (33.33%)		11-03 16:00
Open: 0.015 High: 0.02 Volume: 28,675		Pre. Close: 0.015 Low: 0.0135 Market Cap: 15(M)

Short term
Mid term
Targets	6-month :	0.02	1-year :	0.02
Resists	First :	0.01	Second :	0.02
Pivot price	0.01
Supports	First :	0.01	Second :	0
MAs	MA(5) :	0.01	MA(20) :	0.01
	MA(100) :	0.01	MA(250) :	0.02
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	44.4	D(3) :	35.1
RSI	RSI(14): 71.7
52-week	High :	0.07	Low :	0

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ EMOR ] has closed It is unclear right now based on current values. 40.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	0.02 - 0.02	0.02 - 0.02
Low:	0.01 - 0.01	0.01 - 0.01
Close:	0.01 - 0.01	0.01 - 0.01

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa Inc. also operates digital pharmacy marketplace. The company was formerly known as Emerald Organic Products Inc. and changed its name to Healixa Inc. in April 2021. The company was founded in 1977 and is based in Holbrook, New York.

Tue, 20 Dec 2022
Healixa Inc. Appoints Former Pennsylvania Senator Richard Alloway II as Executive Vice President for Government Relations - Yahoo Finance

Thu, 01 Dec 2022
Healixa taps former US Acting Secretary of Defense Christopher C Miller for advisory board appointment - Proactive financial news

Thu, 01 Dec 2022
Healixa Inc. Appoints Former Acting Secretary of Defense of - GlobeNewswire

Tue, 09 Nov 2021
Healixa’s Subsidiary PurelyRx Launches Its New Satellite Location - GlobeNewswire

Tue, 04 Nov 2025

Tue, 04 Nov 2025

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: OTC
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	766 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.